Microparticles: Bridging the Gap between Autoimmunity and Thrombosis

Elena Niccolai1, Giacomo Emmi1, Danilo Squatrito1

  • 1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Insights

Microparticles (MPs), small vesicles released from cells, are linked to inflammation and autoimmune diseases. This review explores how MPs promote blood clotting in autoimmune conditions, contributing to thrombotic events.

Area of Science:

  • Immunology
  • Hematology
  • Pathophysiology

Background:

  • Microparticles (MPs) are cell-derived vesicles implicated in inflammation and autoimmunity.
  • MPs can act as autoantigen sources, forming immune complexes.
  • Autoimmune diseases are increasingly associated with thrombotic risks, with MPs potentially playing a role.

Purpose of the Study:

  • To review the procoagulant properties of circulating microparticles.
  • To analyze the contribution of microparticles to the pathogenesis of autoimmune diseases.

Main Methods:

  • Literature review focusing on microparticle procoagulant activity.
  • Analysis of studies linking microparticles to autoimmune disease pathogenesis and thrombosis.

Main Results:

  • Microparticles exhibit procoagulant properties.
  • Evidence suggests MPs contribute to inflammation-induced hypercoagulability.
  • MPs are involved in the pathogenesis of thrombotic phenomena in autoimmune diseases like SLE, APS, and vasculitis.

Conclusions:

  • Circulating microparticles possess significant procoagulant potential.
  • Microparticles play a crucial role in the development of thrombosis associated with autoimmune disorders.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.9K